Large-scale testing (Phase 3)Study completedNCT05459532
What this trial is testing
A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa
Who this might be right for
COVID-19
University of Witwatersrand, South Africa 59